Targeted pill tested against hard-to-treat cancers
NCT ID NCT05798611
Summary
This study tested an oral medication called ART0380 for people with advanced or metastatic solid tumors that have specific weaknesses in their DNA repair system. It aimed to see if the drug could shrink tumors and was safe. The trial was designed for 36 participants, including those with recurrent endometrial cancer and other solid tumors, but was terminated early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Francois Baclesse - Service d'Oncologie médicale
Caen, NAP, 14076, France
-
Centre Hospitalier Universitaire De Poitiers
Poitiers, NAP, 86000, France
-
Dana Farber Cancer Center
Boston, Massachusetts, 02215, United States
-
Fundación Instituto Valenciano De Oncología
Valencia, 46009, Spain
-
Hopital Cochin Saint Vincent De Paul
Paris, NAP, 75014, France
-
Hopital Lyon Sud
Pierre-Bénite, NAP, 69310, France
-
Hospital Universitario De Jaén
Jaén, Andalusia, 23007, Spain
-
Institut de Cancérologie de l'Ouest
Angers, NAP, 49055, France
-
Memorial Sloan Kettering Cancer Center (MSKCC) - Memorial Hospital - Oncology
New York, New York, 10065, United States
-
Northwell Health R.J. Zuckerberg Cancer Center
Lake Success, New York, 11042, United States
-
The University of Chicago
Chicago, Illinois, 60637-1447, United States
-
University of California Los Angeles (UCLA)
Los Angeles, California, 90095-1781, United States
-
University of Oklahoma/Sarah Cannon Research Institute
Oklahoma City, Oklahoma, 73104, United States
-
Western Pennsylvania Hospital
Pittsburgh, Pennsylvania, 15224, United States
-
Women and Infants Hospital
Providence, Rhode Island, 02905, United States
Conditions
Explore the condition pages connected to this study.